< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine

Promoter Polymorphism of Vitamin D Receptor Gene Is Associated with Psoriasis Risk and Lower Allele-Specific Expression

Authors: Richetta AG et. al., D'Amico C, et al.

Date: 2014

Scope of interest: Molecular pathology


Read details
Magazine 3.4

Superinfections in patients treated with Teicoplanin as an anti-SARS-CoV-2 agent.

Authors: Ceccarelli G et al

Date: jan 2021

Scope of interest: infectious disease


Read details
Magazine 18.31

An Italian multicentre study of perampanel in progressive myoclonus epilepsies.

Authors: Canafoglia L, Barbella G, Ferlazzo E, Striano P, Magaudda A, d 'Orsi G, Martino T, Avolio C, Aguglia U, Sueri C, Giuliano L, Sofia V, Zibordi F, Ragona F, Freri E, Costa C, Nardi Cesarini E, Fanella M, Rossi Sebastiano D, Riguzzi P, Gambardella A, Di Bonaventura C, Michelucci R, Granata T, Bisulli F, Licchetta L, Tinuper P, Beccaria F, Visani E, Franceschetti S

Date: 2019

Scope of interest: Epilepsy


Read details